Clinical Trials - Post Trial Access
Upon completion of a clinical trial , treatment to participating patients through a post-trial access program is one option.. Simply put, this is ‘continued access’ after completing a trial, if deemed medically necessary. Different countries use different terminology and have country-specific regulatory requirements. In the United States, post-trial access can be provided through one of three pathways: Individual IND, Intermediate Expanded Access Protocol, or Treatment IND. Early Access Care consultant services will provide guidance on options most suitable for client specifications. Our EAC team provides services to support all three. Speak with our team at Booth 23076...
More Info Less Info